FIGURE
Figure 3
- ID
- ZDB-FIG-200511-30
- Publication
- Volpatti et al., 2020 - Identification of drug modifiers for RYR1 related myopathy using a multi-species discovery pipeline
- Other Figures
-
- Figure 1
- Figure 2
- Figure 2-figure supplement 1
- Figure 2-figure supplement 2
- Figure 2-figure supplement 3
- Figure 2-figure supplement 4
- Figure 2-figure supplement 5
- Figure 3
- Figure 3-figure supplement 1
- Figure 4
- Figure 4-figure supplement 1
- Figure 4-figure supplement 2
- Figure 4-figure supplement 3
- Figure 5
- Figure 5-figure supplement 1
- Figure 5-figure supplement 2
- Figure 5-figure supplement 3
- Figure 5-figure supplement 4
- All Figure Page
- Back to All Figure Page
Figure 3
Schematic of our zebrafish screen methodology showing the expected motility of unaffected siblings (‘WT Siblings’) and double mutants (‘Dbl Mut’) and expected motility of immotile double mutants if a chemical suppressed the phenotype. We did not identify any suppressors of the double mutant phenotype |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Elife